We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-13.43%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$3.34B
AUM Growth
+$700M
Cap. Flow
+$1.16B
Cap. Flow %
34.73%
Top 10 Hldgs %
13.4%
Holding
2,173
New
1,007
Increased
282
Reduced
183
Closed
575

Top Sells

Rank Stock Value
1
PBCT
People's United Financial Inc
PBCT
+$63.3M
2
NEM icon
Newmont
NEM
+$40.1M
3
LOW icon
Lowe's Companies
LOW
+$37.7M
4
MMM icon
3M
MMM
+$37.3M
5
FTNT icon
Fortinet
FTNT
+$33.5M

Sector Composition

Rank Sector Weight
1 Technology 15.01%
2 Healthcare 11.5%
3 Industrials 10.54%
4 Energy 9.72%
5 Consumer Discretionary 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IE icon
1526
Ivanhoe Electric
IE
$1.43B
$87K ﹤0.01%
+10,000
New +$97.4K
PYXS icon
1527
Pyxis Oncology
PYXS
$165M
$87K ﹤0.01%
+36,415
New +$96.9K
UXIN
1528
Uxin Ltd
UXIN
$330M
$86K ﹤0.01%
+2,051
New +$123K
RTB
1529
RTB Digital
RTB
$212M
$85K ﹤0.01%
+230
New +$222K
SBS icon
1530
Sabesp
SBS
$19.7B
$83K ﹤0.01%
53,648
-521,119
-91% -$939K
APLT
1531
DELISTED
Applied Therapeutics
APLT
$82K ﹤0.01%
+86,600
New +$142K
LILA icon
1532
Liberty Latin America Class A
LILA
$1.51B
$81K ﹤0.01%
+15,309
New +$95.4K
KBAL
1533
DELISTED
Kimball International
KBAL
$81K ﹤0.01%
+10,516
New +$86.1K
FIRY
1534
Firy Inc
FIRY
$127M
$80K ﹤0.01%
3,226
-48,801
-94% -$1.9M
CLYM
1535
Climb Bio
CLYM
$735M
$80K ﹤0.01%
+26,364
New +$125K
VIRC icon
1536
Virco
VIRC
$94.4M
$79K ﹤0.01%
+20,612
New +$64.6K
VIEW
1537
DELISTED
View, Inc. Class A Common Stock
VIEW
$79K ﹤0.01%
808
-3,919
-83% -$349K
APEN
1538
DELISTED
Apollo Endosurgery, Inc.
APEN
$78K ﹤0.01%
+21,424
New +$101K
SPRO icon
1539
Spero Therapeutics
SPRO
$68.9M
$76K ﹤0.01%
+102,408
New +$298K
ERNA icon
1540
Eterna Therapeutics
ERNA
$4.58M
$75K ﹤0.01%
+19
New +$136K
SYRE icon
1541
Spyre Therapeutics
SYRE
$8.87B
$74K ﹤0.01%
+5,888
New +$206K
CURV icon
1542
Torrid Holdings
CURV
$247M
$73K ﹤0.01%
+17,000
New +$95.4K
SPRB
1543
Spruce Biosciences
SPRB
$119M
$73K ﹤0.01%
+559
New +$71.6K
TISI icon
1544
Team
TISI
$77.7M
$72K ﹤0.01%
+9,639
New +$133K
OPK icon
1545
Opko Health
OPK
$921M
$71K ﹤0.01%
+28,039
New +$81.8K
TBIO
1546
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$71K ﹤0.01%
+2,198
New +$152K
GOCO
1547
DELISTED
GoHealth
GOCO
$70K ﹤0.01%
+7,773
New +$90.4K
AGFS
1548
DELISTED
AgroFresh Solutions Inc
AGFS
$68K ﹤0.01%
37,731
-7,379
-16% -$13.1K
FBRX icon
1549
Forte Biosciences
FBRX
$1.12B
$66K ﹤0.01%
+2,016
New +$64K
KALA icon
1550
KALA BIO
KALA
$11.8M
$66K ﹤0.01%
+88
New +$138K

Similar funds

Ergoteles's Q2 2022 Portfolio in Review

As of Q2 2022, Ergoteles held 2,173 positions worth $3.34B, up 26% from $2.64B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Ergoteles deployed $1.16B of net new capital in Q2 2022, opening 1,007 new positions and adding to 282 existing holdings. Its largest new stake was NXP Semiconductors: 315,378 shares worth $46.7M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Lowe's Companies, an estimated $37.7M trimmed.

  • Ergoteles's largest Q2 2022 buy was NXP Semiconductors: 315,378 shares worth $46.7M.
  • Ergoteles added most to State Street Technology Select Sector SPDR ETF in Q2 2022, an estimated $58.7M increase.
  • Ergoteles's biggest Q2 2022 reduction was Lowe's Companies, cutting an estimated $37.7M.
  • Ergoteles fully exited People's United Financial Inc in Q2 2022, selling an estimated $63.3M.
  • Ergoteles's ten largest holdings make up 13% of its $3.34B portfolio in Q2 2022.
  • Ergoteles opened 1,007 new positions and closed 575 in Q2 2022.
  • Ergoteles's portfolio value rose 26% quarter-over-quarter to $3.34B.

Based on Ergoteles's 13F filing for Q2 2022, filed 12 Aug 2022.